Boxer, A L <br/><br/>
Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.  [electronic resource] 

 -  Neurology  Apr 2005 
 - 1431-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.WNL.0000158476.74580.A8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticoagulants--therapeutic use<br/>Betaine--therapeutic use<br/>Cognition Disorders--drug therapy<br/>Confusion--drug therapy<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Folic Acid--therapeutic use<br/>Frontal Lobe--metabolism<br/>Homocysteine--antagonists & inhibitors<br/>Humans<br/>Hyperhomocysteinemia--complications<br/>Leukoaraiosis--diagnosis<br/>Magnetic Resonance Imaging<br/>Male<br/>Methylmalonic Acid--blood<br/>Remission Induction<br/>Seizures--drug therapy<br/>Treatment Outcome<br/>Vitamin B 12--metabolism<br/>Vitamin B 6--therapeutic use